 CHARLOTTESVILLE, VA ACCESSWIRE May 28, 2020 Adial Pharmaceuticals, Inc. NASDAQ:ADIL; ADILW, a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced the appointment of Dr. Jack Reich to the Board of Directors. Dr. Reich will serve on the Audit Committee as well as the Nominations and Corporate Governance Committee. 